First Treatment for Serious Complications of Kidney Disease, Parathyroid Cancer

Tagged:  

Reports on the approval of Sensipar or cinacalcet, a drug from Amgen Inc. for treating secondary hyperparathyroidism in patients with chronic kidney disease who are on dialysis. Health implicati...

Share this with your friends
AttachmentSize
First Treatment for Serious Complications of Kidney Disease, Parathyroid Cancer.pdf233.92 KB